Its about how those pounds stick around, no matter how hard you try
The field also receives less research funding compared with other diseases
As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
Review the signs and symptoms of hypoglycemia with RY and appropriate methods for treatment hypoglycemic events should they occur (eg, Rule of 15)
How do Liraglutide and Semaglutide differ in their weight loss effects
The FDA label, and therefore the insurance coverage, was not